T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity
- PMID: 2258695
- PMCID: PMC2188765
- DOI: 10.1084/jem.172.6.1547
T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity
Abstract
This study has examined the cellular and humoral responses underlying the rejection of rat renal allografts bearing an isolated RT1Aa class I MHC disparity. RT1Aa disparate kidneys were rejected promptly by high responder RT1u but not by low responder RT1c recipients (median survival time 10 d and greater than 100 d, respectively). The magnitude and phenotype of the cellular infiltrate were similar in rejecting and nonrejecting RT1Aa disparate kidneys. Paradoxically, graft infiltrating cells and spleen cells from RT1u recipients showed minimal ability to lyse donor strain lymphoblasts in vitro, whereas effector cells from RT1c recipients showed modest levels of cytotoxicity. Injection of RT1u rats with MRC OX8 mAb was highly effective at selectively depleting CD8+ cells from graft recipients but had no effect in prolonging the survival of RT1Aa disparate grafts despite the complete absence of CD8+ cells from the graft infiltrate, which included numerous CD4+ T cells and macrophages. RT1u, but not RT1c, recipients mounted a strong alloantibody response against RT1Aa disparate kidneys. Immune serum obtained from RT1u recipients that had rejected a RT1Aa disparate graft was able, when injected into cyclosporin-treated RT1u recipients, to restore their ability to reject a RT1Aa, but not a third-party RT1c, kidney. These results suggest that CD8+ cells in general and CD8+ cytotoxic effector cells in particular are unnecessary for the rapid rejection of RT1Aa class I disparate kidney grafts by high responder RT1u recipients. By implication, CD4+ T cells alone are sufficient to cause prompt rejection of such grafts and they may do so by providing T cell help for the generation of alloantibody.
Similar articles
-
CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody.Eur J Immunol. 1993 Sep;23(9):2078-84. doi: 10.1002/eji.1830230906. Eur J Immunol. 1993. PMID: 8103742
-
Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.Transplantation. 1990 Jan;49(1):175-83. doi: 10.1097/00007890-199001000-00039. Transplantation. 1990. PMID: 2301009
-
The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses.Transplantation. 1993 Sep;56(3):672-80. doi: 10.1097/00007890-199309000-00033. Transplantation. 1993. PMID: 7692630
-
The role of the macrophage in cardiac allograft rejection in the rat.Immunol Rev. 1984;77:143-66. doi: 10.1111/j.1600-065x.1984.tb00720.x. Immunol Rev. 1984. PMID: 6370831 Review.
-
The role of minor histocompatibility alloantigens in penetrating keratoplasty.Dev Ophthalmol. 2003;36:74-88. doi: 10.1159/000067655. Dev Ophthalmol. 2003. PMID: 12494683 Review.
Cited by
-
Perspectives in transplantation immunology 1991.Klin Wochenschr. 1991 Sep 3;69(13):623-8. doi: 10.1007/BF01649326. Klin Wochenschr. 1991. PMID: 1753685 Review.
-
C6 produced by macrophages contributes to cardiac allograft rejection.Am J Pathol. 1999 Oct;155(4):1293-302. doi: 10.1016/S0002-9440(10)65231-5. Am J Pathol. 1999. PMID: 10514411 Free PMC article.
-
Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential.J Immunol. 2018 Dec 15;201(12):3780-3792. doi: 10.4049/jimmunol.1800683. Epub 2018 Nov 14. J Immunol. 2018. PMID: 30429288 Free PMC article.
-
Activation and Regulation of Indirect Alloresponses in Transplanted Patients With Donor Specific Antibodies and Chronic Rejection.Transpl Int. 2024 Aug 20;37:13196. doi: 10.3389/ti.2024.13196. eCollection 2024. Transpl Int. 2024. PMID: 39228658 Free PMC article. Review.
-
Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.J Exp Med. 1992 Jun 1;175(6):1521-9. doi: 10.1084/jem.175.6.1521. J Exp Med. 1992. PMID: 1588278 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials